ISIS-3521 analogs

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameISIS-3521 analogs
Drug Alias NameISIS-12373ISIS-9533ISIS-8007
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionProtein kinase C alpha inhibitorsAnticancer protein kinase inhibitorsAntisense oligonucleotide inhibitors
TargetsProtein kinase C alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIonis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A